Manatū Hauora | Ministry of Health. The Ministry of Health – Manatū Hauora has developed a snapshot report to monitor the progress the health system is making on delivery against the Interim Government Policy Statement on Health 2022–2024 (iGPS). The iGPS set the...

Manatū Hauora | Ministry of Health. In June 2023, the Public Health Agency, within the Ministry of Health, commissioned research and evaluation agency Verian to undertake a series of research projects and population surveys into attitudes and behaviours related to...

Health Committee. In accordance with the Government’s commitment to allow the sale of cold and flu medication containing pseudoephedrine, the purpose of this Bill is to change the classification of pseudoephedrine as a controlled drug. This Bill reclassifies...

The Radiation Safety Act 2016 (the Act) is administered by the Manatū Hauora – the Ministry of Health (the Ministry). Section 86(1) of the Act allows the Director for Radiation Safety (Director) to issue codes of practice. This is for the purpose of specifying technical requirements.

Summary of Māori feedback on the inclusion of rongoā in the Therapeutic Products Bill (201-4) to the Ministry of Health.

The Statement of Intent (SOI) is published every three years. This document provides an overview of our strategic priorities for the next four years, as well as specific performance targets and measures.

he purpose of the Therapeutic Products Bill is to protect, promote, and improve the health of all New Zealanders.

During 2021 and 2022, the Pharmacy Team from Manatu Hauora - Ministry of Health and Te Whatu Ora – Health New Zealand consulted widely with consumer and whānau groups throughout Aotearoa.

The intent was to provide an opportunity for consumer groups to share their honest experiences of pharmacy with us along with suggestions for things that could be done better.

Additional Expectations of Pharmac arising from the Government response to the independent review.